Carboxylated Pocoa polysaccharides inhibited oxidative damage and inflammation of HK-2 cells induced by calcium oxalate nanoparticles
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved..
The inhibitory effects of Chinese medicine Pocoa (PCPs) with different carboxyl group (-COOH) contents on oxidative damage and inflammatory response of renal epithelial cells and the influence of -COOH content in polysaccharides were investigated. HK-2 cell damage model was established by nanocalcium oxalate crystals (nanoCOM), and then PCPs with -COOH contents of 2.56% (PCP0), 7.48% (PCP1), 12.07% (PCP2), and 17.18% (PCP3) were used to protect the cells. PCPs could inhibit the damage of nanoCOM to HK-2 cells, increase cell viability, restore cytoskeleton and morphology, and improve lysosomal integrity. PCPs can reduce the oxidative stress response of nanoCOM to cells, inhibit the opening of mPTP and cell necrotic apoptosis, reduce the level of Ca2+ ions in cells, the production of ATP and MDA, and increase SOD expression. PCPs can also reduce the cellular inflammatory response caused by oxidative damage, and reduce the expression of nitric oxide (NO), inflammatory factors TNF-α, IL-6, IL-1β and MCP-1, as well as the content of inflammasome NLRP3. After protection, PCPs can inhibit the endocytosis of nanoCOM crystals by cells. With the increase in -COOH content in PCPs, its ability to inhibit nanoCOM cell damage, reduce oxidative stress, reduce inflammatory response, and inhibit crystal endocytosis increases, that is, PCP3 with the highest -COOH content, shows the best biological activity. Inhibiting cell damage and inflammation and reducing a large amount of endocytosis of crystals by cells are beneficial to inhibit the formation of kidney stones.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:169 |
---|---|
Enthalten in: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 169(2023) vom: 31. Dez., Seite 115865 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xiong, Peng [VerfasserIn] |
---|
Links: |
---|
Themen: |
2612HC57YE |
---|
Anmerkungen: |
Date Completed 07.12.2023 Date Revised 07.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.biopha.2023.115865 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364640391 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM364640391 | ||
003 | DE-627 | ||
005 | 20231226095842.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biopha.2023.115865 |2 doi | |
028 | 5 | 2 | |a pubmed24n1215.xml |
035 | |a (DE-627)NLM364640391 | ||
035 | |a (NLM)37972469 | ||
035 | |a (PII)S0753-3322(23)01663-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xiong, Peng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Carboxylated Pocoa polysaccharides inhibited oxidative damage and inflammation of HK-2 cells induced by calcium oxalate nanoparticles |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.12.2023 | ||
500 | |a Date Revised 07.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved. | ||
520 | |a The inhibitory effects of Chinese medicine Pocoa (PCPs) with different carboxyl group (-COOH) contents on oxidative damage and inflammatory response of renal epithelial cells and the influence of -COOH content in polysaccharides were investigated. HK-2 cell damage model was established by nanocalcium oxalate crystals (nanoCOM), and then PCPs with -COOH contents of 2.56% (PCP0), 7.48% (PCP1), 12.07% (PCP2), and 17.18% (PCP3) were used to protect the cells. PCPs could inhibit the damage of nanoCOM to HK-2 cells, increase cell viability, restore cytoskeleton and morphology, and improve lysosomal integrity. PCPs can reduce the oxidative stress response of nanoCOM to cells, inhibit the opening of mPTP and cell necrotic apoptosis, reduce the level of Ca2+ ions in cells, the production of ATP and MDA, and increase SOD expression. PCPs can also reduce the cellular inflammatory response caused by oxidative damage, and reduce the expression of nitric oxide (NO), inflammatory factors TNF-α, IL-6, IL-1β and MCP-1, as well as the content of inflammasome NLRP3. After protection, PCPs can inhibit the endocytosis of nanoCOM crystals by cells. With the increase in -COOH content in PCPs, its ability to inhibit nanoCOM cell damage, reduce oxidative stress, reduce inflammatory response, and inhibit crystal endocytosis increases, that is, PCP3 with the highest -COOH content, shows the best biological activity. Inhibiting cell damage and inflammation and reducing a large amount of endocytosis of crystals by cells are beneficial to inhibit the formation of kidney stones | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Anti-inflammation | |
650 | 4 | |a Carboxymethylated polysaccharide | |
650 | 4 | |a Cytoendocytosis | |
650 | 4 | |a Nanocrystals | |
650 | 4 | |a Oxidative damage | |
650 | 7 | |a Calcium Oxalate |2 NLM | |
650 | 7 | |a 2612HC57YE |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
700 | 1 | |a Zheng, Yu-Yun |e verfasserin |4 aut | |
700 | 1 | |a Ouyang, Jian-Ming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |d 1984 |g 169(2023) vom: 31. Dez., Seite 115865 |w (DE-627)NLM012645591 |x 1950-6007 |7 nnns |
773 | 1 | 8 | |g volume:169 |g year:2023 |g day:31 |g month:12 |g pages:115865 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biopha.2023.115865 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 169 |j 2023 |b 31 |c 12 |h 115865 |